12C. ASRH Invited Speaker Session: Clinical management: Using high resolution anoscopy and HPV Screening Strategies
Tracks
| Wednesday, September 16, 2026 |
| 2:00 PM - 3:30 PM |
Details
Learning objectives:
- describe current approaches to HPV screening and anal cancer prevention
- identify opportunities and challenges in establishing HRA services
- reflect on anal cancer assessment and management in priority populations
Speaker
A/Prof Vincent Cornelisse
Staff Specialist
NSW Health
Setting up a service in north NSW
Biography
Vincent is a specialist in sexual health medicine in Sydney. In addition to his medical qualifications he holds a PhD in sexual health epidemiology, and his research focuses mainly on the prevention of HIV and other STIs.
Dr Mary Poynten
Senior Lecturer
The Kirby Institute
Guidelines insight
Biography
Mary is a clinical epidemiologist at the Kirby Institute, UNSW. She is the chief investigator on a number of anal cancer prevention studies and was chair of the ASHM anal cancer screening guidelines committee.
Professor Richard Hillman
Senior Staff Specialist
HIV & Immunology, St Vincent's Hospital, Darlinghurstntre
Overview of HRA service
Biography
Richard Hillman runs the Dysplasia and Anal Cancer Services at St Vincent's Hospital, Sydney, where the SPANC study and Gardasil trials were held. He is a past President of the International Anal Neoplasia Society and led the development of the international guidelines for the practice of HRA and DARE.
Dr Ian Wong
Infectious diseases Staff Specialist
St. Vincent’s Hospital Darlinghurst
Implementation of anal cancer screening guidelines in practice
4:15 PM - 4:30 PMBiography
Ian Wong is a Staff Specialist at St Vincent's Hospital Dysplasia and Anal Cancer Services.
